Judge Andrews Issues Markman Ruling in Infringement Action Construing Three Terms in Dispute in Asserted Claims in Patents-in-Suit

By Memorandum Opinion entered by The Honorable Richard G. Andrews in Novartis Pharmaceuticals Corp. et al. v. Mylan Pharmaceuticals Inc., Civil Action No. 17-389-RGA (D.Del. June 29, 2018), the Court rendered its Markman ruling construing three (3) terms in dispute in the asserted claims of U.S. Patent Nos. 8,778,962 (“the ‘962 patent”) and 8,617,598 (“the ‘598 patent”). A copy of the Memorandum Opinion is attached.

Read more detail on Recent Antitrust posts –

This entry was posted in Antitrust - Competition law and tagged , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply